Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smell in Covid-19 and Efficacy of Nasal Theophylline

NCT04789499 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04789499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04789499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smell in Covid-19 and Efficacy of Nasal Theophylline
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
March 15, 2021
Completion date
December 30, 2021
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ageusia, anosmia, covid-19 pandemic, covid19, hypogeusia, hyposmia, olfactory disorder, sars-cov-2 infection